Screener
Summit Therapeutics SMMT Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Summit Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Summit Therapeutics’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001599298-26-000039
FAQ
- What is Summit Therapeutics's current ratio?
- Summit Therapeutics (SMMT) reported current ratio of 7.4× in Q1 2026.
- How has Summit Therapeutics's current ratio changed year-over-year?
- Summit Therapeutics's current ratio decreased by 30.3% year-over-year, from 10.6× to 7.4×.
- What is the long-term trend for Summit Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Summit Therapeutics's current ratio has grown at a 17.5% compound annual growth rate (CAGR), from 4.4× to 9.9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Summit Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude